Resident Supervision Index: Assessing Feasibility and Validity

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00680368
First received: May 16, 2008
Last updated: April 6, 2015
Last verified: August 2014
  Purpose

OBJECTIVES: To develop, assess feasibility, and test the validity of the Resident Supervision Index (RSI), a survey tool for medical residents designed to measure quantitatively the level of supervision the resident received while caring for an outpatient during a patient care encounter.

RESEARCH DESIGN: This is a prospective trial assessing the Residency Supervision Index (Index) applied to outpatient care encounters for content validity, test-retest reliability, and construct validity.


Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Resident Supervision Index: Assessing Feasibility and Validity

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Intraclass Correlation Coefficient Between Physician Resident and Attending Physician. [ Time Frame: 24-hours ] [ Designated as safety issue: No ]
    Describes agreement between physician resident and attending physician assessment of total resident supervision time for a given patient and patient care clinical encounter.


Secondary Outcome Measures:
  • Intraclass Correlation Coefficient Assessing Test-retest Reliability for Resident Physicians [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
    Assesses the test-retest reliability of repeated responses for resident physicians only to report the total time spent during resident supervision.

  • Intraclass Correlation Coefficient for Test-retest Reliability for Attending Physicians [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
    Assesses the test-retest reliability among repeated responses to surveys administered to attending physicians only.


Biospecimen Retention:   None Retained

The study did not involve a biospecimen. None was collected. None was retained.


Enrollment: 97
Study Start Date: March 2008
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
Residents and Attending Physicians
This group contains the residents and the attending physicians who consented to participate in the study. They participated in a survey administered by a research assistant. Both physician resident and attending physicians were administered the survey twice within 24-hours and their test-retest responses were compared for reliability. Responses to attending and resident physicians covering the care for the patient and clinical care encounter were compared for accuracy.

Detailed Description:

OBJECTIVES: To develop, assess feasibility, and test the validity of the Resident Supervision Index (RSI), a survey tool for medical residents designed to measure quantitatively the level of supervision the resident received while caring for an outpatient during a patient care encounter.

RESEARCH DESIGN: This is a prospective trial assessing the Residency Supervision Index (Index) applied to outpatient care encounters for test-retest reliability and construct validity.

METHODOLOGY: Trained interviewers administered the Index during face-to-face and in-clinic interviews with 60 consenting resident physicians and their 37 consenting attending physicians to descsribe the care they provided to 143 patients at the outpatient clinics involving 148 clinical encounters at the Loma Linda VA Medical Center.

For each encounter, data comes from administering the Resident Supervision Index to the resident and attending. Baseline data describing each subject (attending physicians and resident physicians) came from face-to-face interviews.

Test-retest reliability is assessed by re-administering the Index to residents for within 24 hours of the encounter. Concurrent validity is assessed by re-administering the Index to the attending physician responsible for the patient's care.

CLINICAL RELATIONSHIPS: The study will help our understanding of how residents at VA medical centers receive training and are supervised for the purpose of both education and patient outcomes.

IMPACT/SIGNIFICANCE: The instrument is planned for future studies to assess the association between resident supervision and training outcomes, clinical workload, patient outcomes, quality of care, and care costs.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Residents

Criteria

Inclusion Criteria:

  • Males and females
  • Ages 18 and older

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00680368

Locations
United States, California
VA Loma Linda Healthcare System, Loma Linda, CA
Loma Linda, California, United States, 92357
Sponsors and Collaborators
Investigators
Principal Investigator: Terrell Michael Kashner, PhD JD MPH VA Loma Linda Healthcare System, Loma Linda, CA
Principal Investigator: Dale S. Cannon, PhD VA Salt Lake City Health Care System, Salt Lake City, UT
  More Information

Publications:
Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00680368     History of Changes
Other Study ID Numbers: SHP 08-164
Study First Received: May 16, 2008
Results First Received: August 29, 2014
Last Updated: April 6, 2015
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Feasibility
Supervision
Assessing

ClinicalTrials.gov processed this record on May 21, 2015